Concourse Financial Group Securities, Inc. Generation Bio Co. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$2.16 - $3.51 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$2.64 - $4.35 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$1.73 - $4.07 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.91 - $3.35 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$3.65 - $6.9 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$3.65 - $6.9 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$3.5 - $5.67 $0 - $0
Q1 2023 May 15, 2023	BUY	$3.61 - $7.01 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$3.66 - $6.77 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$4.68 - $8.34 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$4.87 - $9.41 $0 - $0
Q1 2022 May 09, 2022	BUY	$4.16 - $7.76 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$5.99 - $24.97 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$20.0 - $27.43 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$24.34 - $38.34 $0 - $0
Q1 2021 May 13, 2021	BUY	$24.74 - $40.2 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$21.68 - $51.61 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$18.07 - $31.84 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$20.1 - $24.69 $0 - $0

Others Institutions Holding GBIO

# of Institutions

Shares Held

49.6M

Call Options Held

Put Options Held

Price T Rowe Associates Inc Baltimore, MD

9.35M
Shares

$12.8 Million
0.0% of portfolio
Atlas Venture Life Science Advisors, LLC

8.28M
Shares

$11.3 Million
2.52% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.92M
Shares

$5.37 Million
0.16% of portfolio
Black Rock Inc. New York, NY

3.29M
Shares

$4.51 Million
0.0% of portfolio
Bank Of America Corp Charlotte, NC

2.98M
Shares

$4.09 Million
0.0% of portfolio

View Full List

About Generation Bio Co.

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $80.8M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

More about GBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account